“Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A Single Center Study”. The Planet 7, no. 01 (February 10, 2024): 255–266. Accessed May 6, 2026. https://bdjournals.org/planet/article/view/427.